Spinal Metastases in Testicular Cancer: Prognosis and Treatment Approaches
Author Information
Author(s): Scalia Gianluca, Ferini Gianluca, Shams Zubayer, Graziano Francesca, Ponzo Giancarlo, Giurato Eliana, Galasso Maria Grazia, Pumo Vitalinda, Caruso Martina, Galvano Gianluca, Marrone Salvatore, Naimo Jessica, Nicoletti Giovanni Federico, Umana Giuseppe Emmanuele
Primary Institution: Neurosurgery Unit, Department of Head and Neck Surgery, Garibaldi Hospital, Catania, Italy
Hypothesis
This systematic review aims to evaluate prognosis and treatment approaches for spinal metastases in non-seminomatous germ cell tumors (NSGCT).
Conclusion
Spinal metastases in NSGCT require a combination of chemotherapy, surgery, and multidisciplinary care for optimal outcomes.
Supporting Evidence
- 100% of patients received chemotherapy, primarily cisplatin-based.
- Spinal cord compression occurred in 59.8% of patients.
- Complete remission was achieved in only 2.4% of cases.
- Progressive improvement was observed in 56.7% of cases.
- 20.1% of patients died from their disease or treatment-related complications.
Takeaway
This study looks at how spinal cancer from testicular tumors can be treated and shows that many patients can improve with the right care, but some still face serious challenges.
Methodology
A systematic review was conducted following PRISMA guidelines, analyzing case reports, case series, and cohort studies related to NSGCT with spinal metastases.
Potential Biases
The retrospective nature of most case reports introduces potential selection and reporting bias.
Limitations
The sample size is small relative to the overall population, and there is significant heterogeneity in clinical outcomes and treatment protocols.
Participant Demographics
Patients aged 23 to 40 years, with a median age of 31.5 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website